# Use of Teriparatide to Accelerate Fracture Healing

> **NCT00594906** · NA · TERMINATED · sponsor: **University of Rochester** · enrollment: 10 (actual)

## Conditions studied

- Pelvic Fracture

## Interventions

- **DRUG:** Teriparatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00594906
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 10 (ACTUAL)
- **Why stopped:** The study was terminated due to poor enrollment.
- **Last updated:** 2014-12-19

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00594906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00594906, "Use of Teriparatide to Accelerate Fracture Healing". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00594906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*